|
Sebaceous Gland Neoplasms
|
C17.800.794.712 |
|
|
D-Aspartic Acid
|
D12.125.119.170.150 |
|
|
Image-Guided Biopsy
|
E01.370.225.998.054.370 |
|
|
Perimeningeal Infections
|
C01.207.709 |
|
|
Mucopolysaccharidosis III
|
C16.320.565.595.600.650 |
|
|
United States Federal Trade Commission
|
I01.409.418.750.968 |
|
|
Mucopolysaccharidosis I
|
C16.320.565.595.600.640 |
|
|
Mercury Isotopes
|
D01.268.956.437.500 |
|
|
Mercury
|
D01.268.956.437 |
|
|
Donepezil
|
D02.455.426.559.847.486.487.280 |
|
|
Venlafaxine Hydrochloride
|
D02.455.426.392.368.367.318.750 |
|
|
Mucopolysaccharidosis II
|
C16.320.565.595.600.645 |
|
|
Anesthetics, Combined
|
D27.505.954.427.210.100.017 |
|
|
Hidradenitis Suppurativa
|
C01.830.499 |
|
|
von Willebrand Diseases
|
C16.320.099.920 |
|
|
Hypocotyl
|
A18.024.937.249 |
|
|
Bradykinin B2 Receptor Antagonists
|
D065094 |
[Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B2 RECEPTORS.
] |
|
Calcineurin Inhibitors
|
D065095 |
[Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.
] |
|
Trichothecenes, Type C
|
D02.455.849.765.850.987 |
|
|
Calcium Chelating Agents
|
D065096 |
[Substances that bind to and sequester CALCIUM ions.
] |
